PALO ALTO, CA (November 10, 2015) – We were disappointed to see yet another inaccurate WSJ article, entirely relying on anonymous sources. As we relayed to the Journal, the information published in this piece is again inaccurate, misleading and defamatory.
No amount of cynical and misleading news coverage will stop us from focusing on our mission and our goals. Theranos remains committed to bringing actionable, accessible and affordable health information to those who need it most. We are committed to sharing data with regulators and with leading medical and scientific institutions. In line with this commitment, we have publicly invited third parties to review, validate, and publish data on our technologies, including in peer-reviewed journals, and are actively engaged in doing so.